aequita pharmacy tirzepatide Warning on GLP-1 Compounds An update on Aequita Pharmacy:

The full patient group submissions are included in the Stakeholder Input section at the end of this report

Los medicamentos pueden ser un complemento valioso, pero no reemplazan estos cambios fundamentales

Participants and Main Measures Patients diagnosed with type 2 diabetes between 20132021 were identified using IBM-MarketScan database and were categorized into exposure (i.e., GLP-1RA) and comparison (i.e., insulin) groups

Common Injection Sites The following are common sites where tirzepatide is often injected: Abdomen: The abdomen is a popular choice for injections

Insurance limitations: Some insurance plans may not cover these medications or impose strict criteria for approval